Researchers warn on peptide misuse

The article discusses the rising popularity and regulatory challenges of peptides like MOTS-c, which are promoted online as performance and longevity enhancers without FDA approval or sufficient human safety data. Experts, including Pinchas Cohen of USC, warn against unregulated self-injection due to unknown risks, while some policymakers advocate for allowing compounding pharmacies to produce these peptides under supervision. The debate highlights the tension between scientific caution and consumer demand driven by social media and wellness trends.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل